결찰기 시장 - 예측(2026-2031년)

Ligation Devices Market is projected to expand at a 5.93% CAGR, attaining USD 2041.259 million in 2031 from USD 1,444.992 million in 2025.

The ligation devices market is a critical segment within the broader surgical instrumentation landscape, providing essential tools for the secure closure of blood vessels and ducts during both open and minimally invasive procedures. These devices, which include clips, sutures, and advanced energy-based ligation systems, are fundamental to achieving hemostasis and ensuring procedural safety across a wide range of surgical specialties. Market growth is primarily driven by the sustained increase in global surgical volumes, a pronounced shift towards minimally invasive techniques, and the rising prevalence of chronic diseases that require surgical intervention, particularly within an aging global population.

A central and powerful driver for the market is the accelerating adoption of minimally invasive surgical (MIS) procedures. This shift is fundamentally reshaping demand for ligation devices, as MIS techniques require specialized instrumentation designed for use through small incisions or via endoscopic and laparoscopic channels. Ligation devices for MIS must offer precision, reliable deployment, and compatibility with long, narrow trocars. The significant clinical benefits associated with MIS-including reduced post-operative pain, shorter hospital stays, lower infection rates, and improved cosmetic outcomes-are compelling healthcare providers and patients alike, thereby increasing procedural volumes and the consumption of compatible devices. The ligation devices market is inherently linked to the expansion of MIS across specialties such as general surgery, urology, and gynecology.

From an application perspective, gastrointestinal and abdominal surgery represents a dominant and high-growth segment. The increasing incidence of gastrointestinal disorders, ranging from colorectal cancer to benign conditions requiring resection, fuels substantial demand for reliable ligation solutions. These procedures, whether performed laparoscopically or via open approaches, necessitate the secure closure of numerous vessels and tissue structures, directly driving the utilization of both disposable and reusable ligation devices. The critical need to prevent post-operative complications like bleeding or leakage underscores the importance of device reliability and surgeon proficiency.

Concurrently, gynecological surgery is a significant and expanding application area. The rising prevalence of conditions such as uterine fibroids, endometriosis, and ovarian cysts, which often require surgical management, contributes to steady market demand. Furthermore, the increasing global focus on women's health and access to surgical care amplifies this trend. Technological advancements have led to the development of specialized ligation devices tailored for gynecological anatomy and procedures, offering improved ergonomics, precision, and safety profiles that appeal to surgeons in this field.

The product landscape is characterized by a sustained preference for handheld and manual ligation instruments, despite the growth of advanced energy-based systems. This segment's resilience is attributed to its versatility, reliability, and cost-effectiveness, particularly in open surgical procedures and in healthcare settings with budgetary constraints. Handheld devices, including clip appliers and ligature carriers, remain fundamental tools in a surgeon's arsenal, especially in oncologic, cardiovascular, and obstetric surgeries where precise vessel control is paramount.

Geographically, the Asia-Pacific region is anticipated to exhibit significant growth, emerging as a dynamic focal point for market expansion. This trajectory is underpinned by several factors: rapidly improving healthcare infrastructure, increasing investments in modern surgical suites, a growing volume of surgical procedures, and the rising prevalence of lifestyle and age-related diseases that necessitate intervention. Local and multinational companies are actively targeting this region through strategic investments in manufacturing, distribution networks, and surgeon training programs to capture this expanding demand.

The competitive environment is marked by strategic consolidation and a focus on portfolio integration. Leading medical device companies are actively pursuing mergers and acquisitions to broaden their ligation product offerings, gain access to novel technologies, and strengthen their commercial presence in key surgical specialties. The strategic goal is often to provide comprehensive procedural solutions, pairing ligation devices with complementary instruments for specific surgical pathways, thereby increasing customer loyalty and procedural efficiency.

Growth strategies for market participants increasingly emphasize beyond the device itself. Companies are investing in comprehensive surgeon education and training initiatives to ensure proper device utilization and optimal patient outcomes. There is a concurrent focus on advancing technical and technological expertise, with research and development efforts directed towards creating next-generation devices that offer enhanced reliability, ease of use, and integration with digital surgical platforms. Success in the market depends on demonstrating clear clinical value, ensuring robust supply chains, and navigating complex regulatory pathways across different regions.

In conclusion, the ligation devices market is evolving in parallel with global surgical trends, characterized by a steady transition towards minimally invasive techniques and an increasing burden of surgical disease. Its growth is sustained by the foundational need for effective hemostasis in nearly all surgical disciplines. Future market development will be shaped by continued innovation in device design for robotic and advanced laparoscopic platforms, strategic alignment with key surgical growth areas like bariatric and oncologic surgery, and the ability to provide cost-effective solutions without compromising performance or patient safety. The market remains a vital and dynamic component of the global surgical ecosystem.

Key Benefits of this Report:

• Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, and other sub-segments.
• Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
• Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape future market developments.
• Actionable Recommendations: Utilize the insights to exercise strategic decisions to uncover new business streams and revenues in a dynamic environment.
• Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

• Historical data from 2021 to 2025 & forecast data from 2026 to 2031
• Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, and Trend Analysis
• Competitive Positioning, Strategies, and Market Share Analysis
• Revenue Growth and Forecast Assessment of segments and regions including countries
• Company Profiling (Strategies, Products, Financial Information, and Key Developments among others.)

Ligation Devices Market Segmentation

• By Type
• Appliers
• Accessories
• By Application
• Cardiovascular Surgery
• Gynecological Surgery
• Gastrointestinal Surgery
• Urological Surgery
• Others
• By End-User
• Hospitals
• Ambulatory Surgical Centers
• Others
• By Geography
• North America
• USA
• Canada
• Mexico
• South America
• Brazil
• Argentina
• Others
• Europe
• Germany
• France
• United Kingdom
• Spain
• Others
• Middle East and Africa
• Saudi Arabia
• UAE
• Others
• Asia Pacific
• China
• India
• Japan
• South Korea
• Indonesia
• Thailand
• Others

TABLE OF CONTENTS

1. EXECUTIVE SUMMARY

2. MARKET SNAPSHOT

• 2.1. Market Overview
• 2.2. Market Definition
• 2.3. Scope of the Study
• 2.4. Market Segmentation

3. BUSINESS LANDSCAPE

• 3.1. Market Drivers
• 3.2. Market Restraints
• 3.3. Market Opportunities
• 3.4. Porter's Five Forces Analysis
• 3.5. Industry Value Chain Analysis
• 3.6. Policies and Regulations
• 3.7. Strategic Recommendations

4. TECHNOLOGICAL OUTLOOK

5. LIGATION DEVICES MARKET BY TYPE

• 5.1. Introduction
• 5.2. Appliers
• 5.3. Accessories

6. LIGATION DEVICES MARKET BY APPLICATION

• 6.1. Introduction
• 6.2. Cardiovascular Surgery
• 6.3. Gynecological Surgery
• 6.4. Gastrointestinal Surgery
• 6.5. Urological Surgery
• 6.6. Others

7. LIGATION DEVICES MARKET BY END-USER

• 7.1. Introduction
• 7.2. Hospitals
• 7.3. Ambulatory Surgical Centers
• 7.4. Others

8. LIGATION DEVICES MARKET BY GEOGRAPHY

• 8.1. Introduction
• 8.2. North America
  • 8.2.1. USA
  • 8.2.2. Canada
  • 8.2.3. Mexico
• 8.3. South America
  • 8.3.1. Brazil
  • 8.3.2. Argentina
  • 8.3.3. Others
• 8.4. Europe
  • 8.4.1. Germany
  • 8.4.2. France
  • 8.4.3. United Kingdom
  • 8.4.4. Spain
  • 8.4.5. Others
• 8.5. Middle East and Africa
  • 8.5.1. Saudi Arabia
  • 8.5.2. UAE
  • 8.5.3. Others
• 8.6. Asia Pacific
  • 8.6.1. China
  • 8.6.2. India
  • 8.6.3. Japan
  • 8.6.4. South Korea
  • 8.6.5. Indonesia
  • 8.6.6. Thailand
  • 8.6.7. Others

9. COMPETITIVE ENVIRONMENT AND ANALYSIS

• 9.1. Major Players and Strategy Analysis
• 9.2. Market Share Analysis
• 9.3. Mergers, Acquisitions, Agreements, and Collaborations
• 9.4. Competitive Dashboard

10. COMPANY PROFILES

• 10.1. Medtronic Plc
• 10.2. Johnson & Johnson
• 10.3. Olympus Corporation
• 10.4. B. Braun SE
• 10.5. Teleflex Incorporated
• 10.6. CONMED Corporation
• 10.7. CooperSurgical
• 10.8. Leo Medical Co., Ltd.
• 10.9. Boston Scientific Corporation
• 10.10. Welfare Medical Ltd.

11. APPENDIX

• 11.1. Currency
• 11.2. Assumptions
• 11.3. Base and Forecast Years Timeline
• 11.4. Key Benefits for the Stakeholders
• 11.5. Research Methodology
• 11.6. Abbreviations